Paragard Litigation
Lawsuits involving Paragard have been consolidated in a federal multidistrict litigation (MDL) in the U.S. District Court for the Northern District of Georgia. Plaintiffs generally allege that the manufacturers designed a defective product and failed to adequately warn consumers and healthcare providers about the risk of device breakage during removal.
Many claims involve situations in which the IUD fractured during extraction, requiring additional procedures or surgery to remove remaining pieces of the device.
Defendants in the litigation include companies involved in the manufacturing, marketing, and distribution of Paragard, including entities affiliated with Teva Pharmaceuticals and CooperSurgical.
Allegations Regarding Product Warnings
A central issue in the litigation is whether users received adequate warnings about the risk of breakage. Although labeling updates have addressed device fracture to some extent, plaintiffs contend that the warnings remain insufficient and do not fully communicate the potential severity of the complications that may occur.
These claims allege that consumers and healthcare providers were not adequately informed of the risks associated with removal before choosing the device.
Ongoing Legal Developments
Paragard litigation continues to move forward as courts evaluate allegations regarding product design, safety, and warnings. Individuals who experienced complications related to device breakage may be monitoring these proceedings as the legal process develops.
The lawsuits seek to determine whether manufacturers can be held responsible for injuries allegedly caused by Paragard and whether affected individuals may be entitled to compensation.
